%0 Journal Article
%A León Delgado, Marta Ximena
%A Campos, Luisa Rodríguez
%A Bastidas Goyes, Alirio Rodrigo
%A Herazo Cubillos, Andrés
%A Martin Arsanios, Daniel
%A Muñoz Ortíz, Juliana
%A Cifuentes Serrano, Annie
%A García Ávila, Paloma
%A Beltrán Caro, Mateo
%8 2019
%@ 0120-3347
%U http://hdl.handle.net/10818/36224
%X Introduction: Heart failure is a chronic, progressive, prevalent
disease, with a high impact on health systems and on the quality
of life of patients and families. Dyspnea is a common symptom
and management with opioids has been proposed.
Objective: To conduct a systematic review of the literature
pertaining to the use of opioids for the management of dyspnea in
patients with stable chronic heart failure, functional class New
York Heart Association (NYHA) II, III, or IV.
Materials and methods: A systematic review was conducted
in the MEDLINE, Embase, Cochrane, OVID, LILACS, and PROSPERO databases of articles published in 5 languages between
January 1, 1995 and July 31, 2018. Studies describing the
administration of any type of opioid for the management of
dyspnea in patients with stable chronic heart failure NYHA II, III,
or IV were included.
Results: Four clinical trials were obtained for the final analysis
with a total number of 70 patients, describing opioid administration for the management of dyspnea in patients with stable
chronic heart failure, NYHA II, III, or IV.
Conclusion: In adult patients with compensated chronic heart
failure under optimum treatment, there is low-quality evidence
that shows benefit with the use of opioids for the management of
dyspnea. For a stronger recommendation, controlled, randomized
studies with a larger number of subjects are required.
%I Revista Colombiana de Anestesiología
%K Palliative care
%K Heart failure
%K Dyspnea
%K Analgesics
%K Opioid
%K Morphine
%T Opioids for the management of dyspnea in patients with heart failure a systematic review of the literature
%R 10.1097/CJ9.0000000000000088
%~ Intellectum